David W Gryska - Net Worth and Insider Trading

David W Gryska Net Worth

The estimated net worth of David W Gryska is at least $10 Million dollars as of 2024-04-24. David W Gryska is the Director of Seagen Inc and owns about 40,253 shares of Seagen Inc (SGEN) stock worth over $9 Million. David W Gryska is the Executive Vice President, CFO of Incyte Corp and owns about 10,970 shares of Incyte Corp (INCY) stock worth over $566,601. David W Gryska is also the CFO of Celgene Corp and owns about 3,228 shares of Celgene Corp (CELG) stock worth over $349,399. Besides these, David W Gryska also holds PDL BioPharma Inc (PDLI) . Details can be seen in David W Gryska's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David W Gryska has not made any transactions after 2022-11-11 and currently still holds the listed stock(s).

Transaction Summary of David W Gryska

To

David W Gryska Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David W Gryska owns 9 companies in total, including GW Pharmaceuticals PLC (GWPH) , PDL BioPharma Inc (PDLI) , and Aerie Pharmaceuticals Inc (AERI) among others .

Click here to see the complete history of David W Gryska’s form 4 insider trades.

Insider Ownership Summary of David W Gryska

Ticker Comapny Transaction Date Type of Owner
GWPH GW Pharmaceuticals PLC 2020-09-14 director
PDLI PDL BioPharma Inc 2020-12-30 director
AERI Aerie Pharmaceuticals Inc 2013-10-25 director
SGEN Seagen Inc 2022-11-11 director
INCY Incyte Corp 2018-02-21 Executive Vice President & CFO
ARGSQ Argos Therapeutics Inc 2014-02-06 director
MYRX Myrexis Inc 2012-05-11 director & Chief Operating Officer
FBRX Forte Biosciences Inc 2023-01-10 director
MNMD Mind Medicine Inc 2023-06-21 director

David W Gryska Latest Holdings Summary

David W Gryska currently owns a total of 4 stocks. Among these stocks, David W Gryska owns 40,253 shares of Seagen Inc (SGEN) as of November 11, 2022, with a value of $9 Million and a weighting of 90.92%. David W Gryska owns 10,970 shares of Incyte Corp (INCY) as of February 21, 2018, with a value of $566,601 and a weighting of 5.6%. David W Gryska also owns 3,228 shares of Celgene Corp (CELG) as of May 4, 2010, with a value of $349,399 and a weighting of 3.45%. The other 1 stocks PDL BioPharma Inc (PDLI) have a combined weighting of 0.03% among all his current holdings.

Latest Holdings of David W Gryska

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGEN Seagen Inc 2022-11-11 40,253 228.74 9,207,471
INCY Incyte Corp 2018-02-21 10,970 51.65 566,601
CELG Celgene Corp 2010-05-04 3,228 108.24 349,399
PDLI PDL BioPharma Inc 2020-12-30 1,387 2.47 3,426

Holding Weightings of David W Gryska


David W Gryska Form 4 Trading Tracker

According to the SEC Form 4 filings, David W Gryska has made a total of 8 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Seagen Inc is the sale of 7,500 shares on November 11, 2022, which brought David W Gryska around $968,250.

According to the SEC Form 4 filings, David W Gryska has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 1,952 shares on February 21, 2018, which brought David W Gryska around $167,013.

According to the SEC Form 4 filings, David W Gryska has made a total of 0 transactions in Celgene Corp (CELG) over the past 5 years. The most-recent trade in Celgene Corp is the sale of 76,186 shares on May 4, 2010, which brought David W Gryska around $2 Million.

More details on David W Gryska's insider transactions can be found in the Insider Trading History of David W Gryska table.

Insider Trading History of David W Gryska

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David W Gryska Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David W Gryska Ownership Network

Ownership Network List of David W Gryska

No Data

Ownership Network Relation of David W Gryska


David W Gryska Owned Company Details

What does GW Pharmaceuticals PLC do?

Who are the key executives at GW Pharmaceuticals PLC?

David W Gryska is the director of GW Pharmaceuticals PLC. Other key executives at GW Pharmaceuticals PLC include Chief Legal Officer Douglas B. Snyder , Chief Medical Officer Volker Knappertz , and Secretary Adam D. George .

GW Pharmaceuticals PLC (GWPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of GW Pharmaceuticals PLC (GWPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GW Pharmaceuticals PLC (GWPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GW Pharmaceuticals PLC (GWPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

GW Pharmaceuticals PLC Insider Transactions

No Available Data

David W Gryska Mailing Address

Above is the net worth, insider trading, and ownership report for David W Gryska. You might contact David W Gryska via mailing address: 749 N Mary Ave, Sunnyvale Ca 94085.

Discussions on David W Gryska

No discussions yet.